The Wharton Moneyball Post Game Podcast


Wharton Moneyball: Wearable Tech, NFL Play Analytics, & Athlete Training

Ep. 161

Show from 7/31/19

In this episode of Wharton Moneyball, as the baseball season gets down to the wire hosts Eric Bradlow and Adi Wyner discuss what teams they think will make it to the 2019 World Series. Then, how can you measure an athletes recovery rate and what external factors impact performance? Our hosts talk to the CEO of WHOOP about their next generation wearable technology. Plus an in depth look at NFL play analytics. You'll find out how to measure the opposing teams offensive tactics and enhance a player's on field experience.


Will Ahmed - Founder and CEO of WHOOP, which has developed next generation wearable technology for optimizing human performance. WHOOP works with professional athletes across every sports league, college athletes across every conference, Olympians and the U.S. military. WHOOP is also the official recovery wearable of the NFL Players Association. 

Follow him on Twitter and Instagram: @willahmed

Check out WHOOP:

Paul Posluszny - Former Pro Bowl linebacker who played 11 seasons in the NFL. He played college football for Penn State University, where earned consensus All-American honors twice, and was chosen by the Buffalo Bills in the second round of the 2007 NFL Draft. He was also a member of the Jacksonville Jaguars for seven seasons before retiring as the franchises all time tackles leader in 2018.  

More Episodes


7/22/2020: COVID-19, Sports, David Fajgenbaum

David Fajgenbaum, MD, MBA, MSc is a groundbreaking physician-scientist, disease hunter, and bestselling author of the acclaimed memoir, Chasing My Cure: A Doctor's Race to Turn Hope Into Action. Fajgenbaum went from being a beast-like college Quarterback to receiving his last rites while in medical school and nearly dying four more times battling Castleman disease. To try to save his own life, he spearheaded an innovative approach to research and discovered a possible treatment that has put him into an extended remission. Now, he is spreading this approach to advance cures for other diseases and sharing lessons he learned about living from nearly dying through Chasing My Cure.One of the youngest individuals ever appointed to the faculty at Penn Medicine and the top 1 percent youngest grant awardees of a leading NIH grant, Dr. Fajgenbaum is co-founder and executive director of the Castleman Disease Collaborative Network (CDCN) and Associate Director, Patient Impact, for the Penn Orphan Disease Center. He has been recognized on the Forbes 30 Under 30 list, as a top healthcare leader by Becker's Hospital Review, the Global Genes RARE Champion of Hope: Science awardee, and one of three recipients--including Vice President Joe Biden--of a 2016 Atlas Award from the World Affairs Council of Philadelphia. Before co-founding the CDCN, Dr. Fajgenbaum co-founded and led the Actively Moving Forward Support Network, a non-profit organization dedicated to supporting grieving college students. Dr. Fajgenbaum has been profiled in a cover story by The New York Times as well as by Good Morning America, CNN, and the Today Show, among others.Dr. Fajgenbaum earned a BS from Georgetown University magna cum laude with honors and distinction, MSc from the University of Oxford, MD from the University of Pennsylvania Medical School, and MBA from The Wharton School. He is a former Division I college quarterback, state-champion weight lifter, and co-founder of a national grief support network.